(Canavan Disease)(Gene Therapy)(Press Release)
Thomas Madore serves as Director of Accounting at Myrtelle. Tom joined the company in 2022 and brings nearly 15 years of experience to the Myrtelle Finance team. Tom most recently led the accounting function at Vedanta Biosciences, Inc., a clinical stage biotech company centered in the microbiome space. At Vedanta, he was responsible for all aspects of the financial close, and managed accounts payable, payroll and government grant reporting. Prior to Vedanta, Tom spent over 6 years as a Manager in Audit Services at Deloitte & Touche in Boston. While at Deloitte, Tom directed and supervised financial statement audits for several SEC clients, including biopharmaceutical, technology, high tech start-ups and Fortune 500 companies. Prior to his career in Accounting, Tom worked as a Trading Desk Manager and Analyst for the Benchmark Company in Boston where he was a formerly licensed NASD Trader holding Series 7, 63 & 55 licenses. Tom holds a B.A. in Economics from Swarthmore College, an MBA from Northeastern University, and is a Certified Public Accountant (“CPA”).
Tom is excited to be a part of an innovative company which aims to help children. As a father of a toddler, Myrtelle’s mission resonates strongly. In his spare time, Tom enjoys spending time with his wife and daughter and sport fishing for striped bass in Boston Harbor.
(Canavan Disease)(Gene Therapy)(Press Release)
(Gene Therapy)
(Gene Therapy)(Q & A)